Financial statements Amerpharma

Balance sheet of Amerpharma

Company age:
Age:
6 y. 30 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of AMERPHARMA

Year
2020
2021
2022
2023
Total assets 7 885 339,38 9 631 115,92 13 025 587,85 14 497 800,06
A. Fixed assets 1 767 237,73 2 892 570,55 8 028 671,36 9 349 640,50
B. Current assets 6 118 101,65 6 738 545,37 4 996 916,49 5 148 159,56
C. Share capital contributions (basic funds) 0,00 - - -
D. Own shares (stocks) 0,00 - - -
Total liabilities 7 885 339,38 9 631 115,92 13 025 587,85 14 497 800,06
A. Equity 1 675 158,09 850 497,49 1 340 629,38 3 142 703,84
B. Liabilities and provisions for liabilities 6 210 181,29 8 780 618,43 11 684 958,47 11 355 096,22
I. Long-term liabilities 447 390,88 370 237,92 5 039 751,51 5 214 781,99
II. Short-term liabilities 4 555 290,54 7 942 389,61 6 334 099,68 5 941 906,03
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.